Following a similar move from Eli Lilly, Pfizer launched a platform Aug. 27 to sell migraine, COVID-19 and flu products directly to consumers.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
Pfizer goes direct to consumer
